Aerosolized dornase alfa (DNase I) for the treatment of severe respiratory failure in COVID-19: a randomized controlled trial
Åkesson et al., Open Forum Infectious Diseases, doi:10.1093/ofid/ofaf246
https://c19early.org/akesson.html